Preventing Gastric Cancer Development by Inhibiting the Virulence of H. pylori Infection

The Cancer Network featured an interview with Dr. Keith Wilson which was published in the journal Oncology.

" Dr. Wilson and his colleagues recently published a study showing that a chemopreventive drug can also act directly on Helicobacter pylori (H. pylori), a bacterium that is the primary cause of gastric cancer."

Submitted by admin on